GENEVA, Switzerland and NEWTON, Mass., Aug. 12, 2022 (GLOBE NEWSWIRE) RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief), and its collaboration partner, Acer Therapeutics Inc. (Nasdaq: ACER)
As a young Catholic coming of age in Eagle Creek, Oregon, during the late 1960s and early 1970s, Bill Idlewine took German classes and spent some time reading the Martin Luther translation of the Bible. This activity, he said, proved to be of great benefit in later years as he embarked upon his journey of faith.
Relief Therapeutics Holding SA / Key word(s): Regulatory Admission Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease 28-Jul-2022
28.07.2022 Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease | Relief Therapeutics Holding SA | News | Nachricht | Mitteilung